Cells and mechanisms involved in natural cell mediated resistance against the yeast-like organism, Cryptococcus neoformans are not well defined. There are three different cell populations in normal unstimulated animals which have the potential to clear cryptococci from tissues. These are polymorphonuclear leukocytes (PMNL), macrophages, and natural killer (NK) cells. Over the past three years, we have studied the effects of natural effector cells on C. neoformans both in vivo and in vitro. From these studies, it is clear that normal mice have cells which have anti-Cryptococcus activity and by numerous criteria, have characteristics matching NK cells. Although NK cells are not capable of sterilizing a culture of 10/3 cryptococci nor totally eliminating C. neoformans from mice infected with 10/4 organisms, they do significantly reduce the numbers of cryptococci in both cases. These findings suggest that NK cells participate along with PMNL and macrophages in initial clearance of cryptococci from host tisuses. NK cells affect C. neoformans by a nonphagocytic mechanism which includes first binding of the NK cells to the organism then later inhibiting the growth of the cryptococci. The lytic effects of cytotoxic T lymphocytes (CTL) and NK cells against appropriate tissue targets appear to be the result of effector cell exocytosis of granules containing cytolytic components. We are proposing that a similar mechanism may be operating in NK cell mediated inhibition of cryptococci growth. However, our earlier studies have shown that the kinetics of NK cell binding to cryptococci and inhibition of cryptococci growth are much slower than with tumor cell targets. This suggests there may be differences in the way the NK cells respond to binding of cryptococci targets versus tumor cell targets and in the active components or the means by which active components of NK cells affect the yeast target. We now propose investigations to gain a basic understanding of interactions of NK cells with cryptococci, a target which is substantially different from previously studied NK targets. To do this we will determine the sequence of steps leading to inhibition of cryptococci growth, study the changes occurring in the effector and target cells after binding using light and electron microscopy techniques, and asses what specific component(s) of the NK cells is responsible for the anti-Cryptococcus activity. These studies should provide new and significant information on the mechanisms of natural cell mediated resistance in cryptococcosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI018895-08
Application #
3128296
Study Section
Microbial Physiology and Genetics Subcommittee 2 (MBC)
Project Start
1989-01-01
Project End
1991-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
8
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Oklahoma Health Sciences Center
Department
Type
School of Medicine & Dentistry
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
McGaha, T; Murphy, J W (2000) CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response. Infect Immun 68:4624-30
Doyle, H A; Murphy, J W (1999) Role of the C-C chemokine, TCA3, in the protective anticryptococcal cell-mediated immune response. J Immunol 162:4824-33
Blackstock, R; Buchanan, K L; Adesina, A M et al. (1999) Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates. Infect Immun 67:3601-9
Dong, Z M; Jackson, L; Murphy, J W (1999) Mechanisms for induction of L-selectin loss from T lymphocytes by a cryptococcal polysaccharide, glucuronoxylomannan. Infect Immun 67:220-9
Murphy, J W; Schafer, F; Casadevall, A et al. (1998) Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans. Infect Immun 66:2632-9
Dong, Z M; Murphy, J W (1997) Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect Immun 65:557-63
Murphy, J W; Zhou, A; Wong, S C (1997) Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production. Infect Immun 65:4564-71
Dong, Z M; Murphy, J W (1996) Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J Clin Invest 97:689-98
Muth, S M; Murphy, J W (1995) Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice. Infect Immun 63:1637-44
Levitz, S M; Mathews, H L; Murphy, J W (1995) Direct antimicrobial activity of T cells. Immunol Today 16:387-91

Showing the most recent 10 out of 23 publications